Log in to save to my catalogue

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabe...

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_649ee880b6ec4a27a475a22720d93c99

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy

About this item

Full title

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy

Publisher

London, England: SAGE Publications

Journal title

Journal of international medical research, 2021-05, Vol.49 (5), p.3000605211012213-3000605211012213

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Objectives
Progranulin (PGRN) is a secreted growth factor that helps to regulate neuronal survival by blocking tumor necrosis factor-alpha (TNFα) receptors. The antioxidant alpha-lipoic acid (ALA) is used in diabetic neuropathy to improve nerve conduction and relieve neuropathic pain, but its effects on PGRN levels have not yet been elucidated.<...

Alternative Titles

Full title

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_649ee880b6ec4a27a475a22720d93c99

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_649ee880b6ec4a27a475a22720d93c99

Other Identifiers

ISSN

0300-0605

E-ISSN

1473-2300

DOI

10.1177/03000605211012213

How to access this item